• S63845 MCL1 Inhibitor: Precision Tools for Apoptosis Researc

  2026-07-08

  The S63845 MCL1 inhibitor enables highly selective, robust activation of mitochondrial apoptosis in MCL1-dependent cancer models. This article provides actionable guidance for experimental setup, troubleshooting, and leveraging unique workflow enhancements, bridging the latest mechanistic insights with practical laboratory execution.

• PP 1 Src Family Tyrosine Kinase Inhibitor: Protocols & Pitfa

  2026-07-08

  PP 1 unleashes precise, nanomolar-scale control over Src-family kinase signaling, enabling advanced interrogation of oncogenic and immune pathways. This guide delivers actionable experimental workflows, troubleshooting tips, and translational insight, leveraging recent breakthroughs in metastatic prostate cancer research.

• Atorvastatin in Precision Vascular and Ferroptosis Research

  2026-07-07

  Explore how Atorvastatin, a leading HMG-CoA reductase inhibitor, is transforming cholesterol metabolism research and ferroptosis-driven oncology. This in-depth review reveals advanced assay design strategies, mechanistic insights, and translational potential not covered by existing guides.

• Ferroptosis Gene Signature and Atorvastatin in HCC Prognosis

  2026-07-07

  This study introduces a novel prognostic model for hepatocellular carcinoma (HCC) based on ferroptosis-related genes and experimentally validates atorvastatin as an inducer of ferroptosis in HCC cells. The findings highlight a new approach for prognosis prediction and therapeutic intervention in HCC, supporting the integration of ferroptosis targeting into translational cancer research.

• 1-Phenyl-2-Pentanol Suppresses Hepatic Stellate Cell Activat

  2026-07-06

  The referenced study identifies 1-phenyl-2-pentanol from Moringa oleifera as a novel inhibitor of hepatic stellate cell activation. By targeting TGF-β1 and Wnt/β-catenin pathways, this compound demonstrates anti-fibrotic potential, providing new mechanistic insights for liver fibrosis research.

• Gallein: Precision G Protein βγ Subunit Inhibitor for GPCR R

  2026-07-06

  Gallein empowers translational researchers with a robust, selective tool for dissecting G protein βγ subunit signaling in oncology, immunology, and cardiometabolic models. Its validated applications—from modulating macrophage polarization to suppressing cancer metastasis and improving cardiac outcomes—set it apart as a next-generation small molecule for advanced GPCR pathway interrogation.

• Lactate-Driven HMGB1 Modification and Release in Sepsis

  2026-07-05

  This study uncovers how extracellular lactate promotes HMGB1 lactylation and acetylation in macrophages, driving its exosomal release during polymicrobial sepsis. The findings highlight novel metabolic-epigenetic mechanisms that enhance vascular permeability and suggest new therapeutic targets for inflammatory disease research.

• Lamotrigine for Sodium Channel & Serotonin Pathway Research

  2026-07-04

  Lamotrigine stands out as a dual-action research tool, enabling precise interrogation of sodium channel signaling and serotonin inhibition in CNS and cardiac models. This guide delivers optimized protocols, troubleshooting strategies, and actionable insights for translational workflows powered by APExBIO’s high-purity compound.

• MG-132 (Z-LLL-al): Unveiling Proteasome Inhibition in Plant

  2026-07-03

  Explore the multifaceted role of MG-132 as a selective peptide aldehyde proteasome inhibitor in apoptosis assays, cell cycle arrest studies, and the latest plant ubiquitination research. This comprehensive article uniquely bridges advanced cancer research with groundbreaking plant biology findings.

• BGJ398 (NVP-BGJ398): Selective FGFR1/2/3 Inhibitor for Oncol

  2026-07-03

  BGJ398 (NVP-BGJ398) is a highly selective inhibitor of FGFR1, FGFR2, and FGFR3, used in oncology research to dissect FGFR-driven malignancies. The compound demonstrates potent nanomolar inhibition, robust apoptosis induction in FGFR-dependent cancer cells, and minimal off-target kinase activity.

• BF1 Gene Deletion in Chicken MHC: Mechanisms and Implication

  2026-07-02

  This study reveals that the minor class I gene BF1 is entirely deleted in B14 and typical B15 chicken MHC haplotypes due to recombination between short imperfect direct repeats. The findings uncover a previously unresolved genetic mechanism, offering new insights into the structural plasticity and evolutionary dynamics of avian MHC regions.

• Indole-3-pyruvic Acid Modulates Th17/Treg Balance in RA via

  2026-07-02

  This study demonstrates that indole-3-pyruvic acid (IPA), a tryptophan-derived metabolite, alleviates rheumatoid arthritis (RA) by activating the aryl hydrocarbon receptor (AhR) pathway and restoring immune cell balance. The findings provide mechanistic evidence for IPA’s immunomodulatory potential in RA models and offer translational insight for future immune modulation strategies.

• Mechanisms of GPER Inhibition by BHPF in Neuroblastoma Cells

  2026-07-01

  This study elucidates how fluorene-9-bisphenol (BHPF), a BPA substitute, directly inhibits G protein-coupled estrogen receptor 1 (GPER/GPCR30) signaling in human neuroblastoma cells. Through combined molecular modeling and experimental genetics, the work reveals key receptor interactions and functional consequences, offering valuable insight into endocrine disruption at the molecular level.

• Optimizing Cell Proliferation Assays with CCK-8: Protocol &

  2026-07-01

  The Cell Counting Kit-8 (CCK-8) delivers unmatched sensitivity for cell proliferation and cytotoxicity assays, streamlining workflows in immunology and cancer research. This guide translates cutting-edge findings on T cell activation into actionable assay strategies, troubleshooting, and advanced applications.

• Pregnenolone Carbonitrile: Precision in PXR-Driven Liver Res

  2026-06-30

  Pregnenolone Carbonitrile empowers researchers with unrivaled control over rodent PXR activation, unlocking reproducible models for hepatic detoxification, antifibrotic studies, and water homeostasis regulation. Recent insights reveal new hypothalamic roles for PCN, extending its utility into translational nephrology and endocrine research.

16504 records 1/1101 page Next 12345 下5页 Last page